POTENTIAL ANTIPSYCHOTIC AGENTS .8. ANTIDOPAMINERGIC PROPERTIES OF A POTENT SERIES OF 5-SUBSTITUTED (-)-(S)-N-[(1-ETHYLPYRROLIDIN-2-YL)METHYL]-2,3-DIMETHOXYBENZAMIDES - SYNTHESIS VIA COMMON LITHIO INTERMEDIATES

被引:26
作者
HOGBERG, T
STROM, P
HALL, H
OGREN, SO
机构
[1] Astra Research Centre AB, CNS Research & Development, Södertälje
关键词
D O I
10.1002/hlca.19900730221
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of 5‐substituted (−)‐(S)‐N‐[(1‐ethylpyrrolidin‐2‐yl)methyl]‐2,3‐diniethoxybenzanndes were made by reaction of the corresponding benzoyl chlorides with (S)‐1‐ethylpyrrolidine‐2‐methylaruine (→ 14–16, 18–21). The acids required were prepared in a regiospecific manner from 5‐bromo‐2,3‐dimethoxybenzoic acid which was protected as dihydrooxazole (→ 4–8), metalated, reacted with various electrophiles (MeI, EtI, BuBr, CC13CCl3 or MeSSMe), and hydrolyzed (→9–13). Alternatively, (‐)‐(S)‐5‐bromo‐N‐[(1‐ethylpyrrolidin‐2‐yl)methyl]‐2,3‐di‐methoxybenzamide was treated with KH followed by BuLi and an electrophile (I2 or Me3SiCl) to give the 5‐iodo and 5‐(trimethylsilyl) derivatives 17 and 22, respectively. All 5‐substituted amides were highly potent inhibitors of [3H]spiperone binding in rat striatal membranes with IC50 values of 0.5 to 5 nM (Table 3). Thus, a relatively large steric bulk can be accomodated in the position para to the 2‐MeO group. This work also supports the notion that a positive as well as negative electrostatic potential can be located in this position. A selected number of derivatives were also investigated in vivo and found to inhibit apomorphine‐induced behavioural responses in the same dose range as haloperidol and raclopride (Table 4). This new group of benzamides is suitable for investigations of dopamine D‐2 receptors in labelled or unlabelled form. Copyright © 1990 Verlag GmbH & Co. KGaA, Weinheim
引用
收藏
页码:417 / 425
页数:9
相关论文
共 41 条
[1]  
BISHOP JE, 1989, 198TH AM CHEM SOC NA
[2]  
BULTEAU G, 1975, Patent No. 2508045
[3]   POTENTIAL NEUROLEPTIC AGENTS .3. CHEMISTRY AND ANTIDOPAMINERGIC PROPERTIES OF SUBSTITUTED 6-METHOXYSALICYLAMIDES [J].
DEPAULIS, T ;
KUMAR, Y ;
JOHANSSON, L ;
RAMSBY, S ;
FLORVALL, L ;
HALL, H ;
ANGEBYMOLLER, K ;
OGREN, SO .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (09) :1263-1269
[4]   POTENTIAL NEUROLEPTIC AGENTS .4. CHEMISTRY, BEHAVIORAL PHARMACOLOGY, AND INHIBITION OF [H-3] SPIPERONE BINDING OF 3,5-DISUBSTITUTED N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-6-METHOXYSALICYLAMIDES [J].
DEPAULIS, T ;
KUMAR, Y ;
JOHANSSON, L ;
RAMSBY, S ;
HALL, H ;
SALLEMARK, M ;
ANGEBYMOLLER, K ;
OGREN, SO .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (01) :61-69
[5]  
DEPAULIS T, 1984, QSAR DESIGN BIOACTIV, P199
[6]  
DEPAULIS T, IN PRESS EUR J MED C
[7]  
DOSTERT P, 1981, Patent No. 2088364
[8]   SYNTHESIS OF [METHOXY-H-3]- AND [METHOXY-C-11]- LABELED RACLOPRIDE - SPECIFIC DOPAMINE-D2 RECEPTOR LIGANDS [J].
EHRIN, E ;
GAWELL, L ;
HOGBERG, T ;
DEPAULIS, T ;
STROM, P .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1987, 24 (08) :931-940
[9]   INTERACTION OF NEUROLEPTIC DRUGS WITH RAT STRIATAL D-1 AND D-2 DOPAMINE-RECEPTORS - A QUANTITATIVE STRUCTURE AFFINITY RELATIONSHIP STUDY [J].
ELTAYAR, N ;
KILPATRICK, GJ ;
VANDEWATERBEEMD, H ;
TESTA, B ;
JENNER, P ;
MARSDEN, CD .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1988, 23 (02) :173-182
[10]   STEREOSELECTIVE BINDING OF 11C-RACLOPRIDE IN LIVING HUMAN-BRAIN - A SEARCH FOR EXTRASTRIATAL CENTRAL D2-DOPAMINE RECEPTORS BY PET [J].
FARDE, L ;
PAULI, S ;
HALL, H ;
ERIKSSON, L ;
HALLDIN, C ;
HOGBERG, T ;
NILSSON, L ;
SJOGREN, I ;
STONEELANDER, S .
PSYCHOPHARMACOLOGY, 1988, 94 (04) :471-478